How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation. Kataoka N, Imamura T. J Cardiovasc Electrophysiol 2025 Feb 5. doi: 10.1111/jce.16591.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kataoka N, Imamura T. How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation. J Cardiovasc Electrophysiol 2025 Feb 5. doi: 10.1111/jce.16591.
PMID: 39909837